For several years now there has been a shift from using fixed pressure shunts to pressure adjustable shunts. These shunts tend to have a lower revision rate and experience fewer complications, such as overdrainage, which makes them more popular among neurosurgeons and patients. However, fixed pressure shunts are still preferred by some neurosurgeons when treating pediatric patients. The fixed pressure devices are smaller and easier to use in these cases. The majority of shunts sold are pressure adjustable even though the ASP is also considerably higher for these devices.
The move towards pressure adjustable shunts will continue over the forecast period as they cannibalize market share from fixed pressure shunts, increasing the market value. The ASP will continue to increase for pressure adjustable shunts as end-users switch to premium-priced products that have additional features such as antimicrobial coating. The ASP will remain relatively stable for fixed pressure shunts, with a slight appreciation due to the incorporation of new features.
Key Topics Covered:
1. Executive Summary
U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview Competitive Analysis Market Trends Market Developments Procedure Numbers Procedure Codes Investigated Markets Included Key Report Updates Version History
2. Disease Overview
2.1 Basic Anatomy 2.2 Disease Pathology And Disorders 2.2.1 Introduction 2.2.2 General Diagnostics And Neurosurgery 2.2.3 Tumor And Brain Cancer 2.2.4 Brain Arteriovenous Malformations 2.2.5 Ischemic Stroke 2.2.6 Brain Aneurysm 2.2.7 Disorders Related To Cerebrospinal Fluids And Intracranial Pressure 2.2.8 Indication For Neuromodulation 2.2.9 Traumatic Brain Injury